348 related articles for article (PubMed ID: 30013318)
1. Antiangiogenic cytokines as potential new therapeutic targets for resveratrol in diabetic retinopathy.
Popescu M; Bogdan C; Pintea A; Rugină D; Ionescu C
Drug Des Devel Ther; 2018; 12():1985-1996. PubMed ID: 30013318
[TBL] [Abstract][Full Text] [Related]
2. Retinal pigment epithelium-secretome: A diabetic retinopathy perspective.
Ponnalagu M; Subramani M; Jayadev C; Shetty R; Das D
Cytokine; 2017 Jul; 95():126-135. PubMed ID: 28282610
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.
Simó R; Carrasco E; García-Ramírez M; Hernández C
Curr Diabetes Rev; 2006 Feb; 2(1):71-98. PubMed ID: 18220619
[TBL] [Abstract][Full Text] [Related]
4. Polyphenol Metabolite Pyrogallol-
Santos DF; Pais M; Santos CN; Silva GA
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768833
[TBL] [Abstract][Full Text] [Related]
5. Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.
Ibrahim AS; Tawfik AM; Hussein KA; Elshafey S; Markand S; Rizk N; Duh EJ; Smith SB; Al-Shabrawey M
Biochim Biophys Acta; 2015 Mar; 1851(3):290-8. PubMed ID: 25562624
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol-delivery vehicle with anti-VEGF activity carried to human retinal pigmented epithelial cells exposed to high-glucose induced conditions.
Ruginǎ D; Ghiman R; Focșan M; Tăbăran F; Copaciu F; Suciu M; Pintea A; Aștilean S
Colloids Surf B Biointerfaces; 2019 Sep; 181():66-75. PubMed ID: 31125919
[TBL] [Abstract][Full Text] [Related]
7. GLUT1 activity contributes to the impairment of PEDF secretion by the RPE.
Calado SM; Alves LS; Simão S; Silva GA
Mol Vis; 2016; 22():761-70. PubMed ID: 27440994
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via PON1.
Chen Y; Meng J; Li H; Wei H; Bi F; Liu S; Tang K; Guo H; Liu W
Exp Eye Res; 2019 Apr; 181():356-366. PubMed ID: 30503749
[TBL] [Abstract][Full Text] [Related]
9. Chrysin Ameliorates Malfunction of Retinoid Visual Cycle through Blocking Activation of AGE-RAGE-ER Stress in Glucose-Stimulated Retinal Pigment Epithelial Cells and Diabetic Eyes.
Kang MK; Lee EJ; Kim YH; Kim DY; Oh H; Kim SI; Kang YH
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30096827
[TBL] [Abstract][Full Text] [Related]
10. Histamine causes an imbalance between pro-angiogenic and anti-angiogenic factors in the retinal pigment epithelium of diabetic retina via H4 receptor/p38 MAPK axis.
Lee BJ; Byeon HE; Cho CS; Kim YH; Kim JH; Che JH; Seok SH; Kwon JW; Kim JH; Lee K
BMJ Open Diabetes Res Care; 2020 Dec; 8(2):. PubMed ID: 33328159
[TBL] [Abstract][Full Text] [Related]
11. pEPito-driven PEDF Expression Ameliorates Diabetic Retinopathy Hallmarks.
Calado SM; Diaz-Corrales F; Silva GA
Hum Gene Ther Methods; 2016 Apr; 27(2):79-86. PubMed ID: 26942449
[TBL] [Abstract][Full Text] [Related]
12. [Role of the retinal pigment epithelium (RPE) in the pathogenesis and treatment of diabetic macular edema (DME)].
Chmielewska K; Robaszkiewicz J; Kosatka M
Klin Oczna; 2008; 110(7-9):318-20. PubMed ID: 19112870
[TBL] [Abstract][Full Text] [Related]
13. The role of the retinal pigment epithelium and Müller cells secretome in neovascular retinal pathologies.
Araújo RS; Santos DF; Silva GA
Biochimie; 2018 Dec; 155():104-108. PubMed ID: 29960032
[TBL] [Abstract][Full Text] [Related]
14. Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.
Holoman NC; Aiello JJ; Trobenter TD; Tarchick MJ; Kozlowski MR; Makowski ER; De Vivo DC; Singh C; Sears JE; Samuels IS
J Neurosci; 2021 Apr; 41(14):3275-3299. PubMed ID: 33622781
[TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor.
Zhang SX; Wang JJ; Gao G; Shao C; Mott R; Ma JX
FASEB J; 2006 Feb; 20(2):323-5. PubMed ID: 16368716
[TBL] [Abstract][Full Text] [Related]
16. High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes.
Matsuoka M; Ogata N; Minamino K; Higuchi A; Matsumura M
Exp Eye Res; 2006 Jan; 82(1):172-8. PubMed ID: 16054135
[TBL] [Abstract][Full Text] [Related]
17. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
[TBL] [Abstract][Full Text] [Related]
18. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
Nam DH; Oh J; Roh JH; Huh K
Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with anti-VEGF does not induce cell aging in primary retinal pigment epithelium.
Schottler J; Randoll N; Lucius R; Caliebe A; Roider J; Klettner A
Exp Eye Res; 2018 Jun; 171():1-11. PubMed ID: 29522724
[TBL] [Abstract][Full Text] [Related]
20. Effects of trans-resveratrol on type 1 diabetes-induced up-regulation of apoptosis and mitogen-activated protein kinase signaling in retinal pigment epithelium of Dark Agouti rats.
Al-Hussaini H; Kittaneh RS; Kilarkaje N
Eur J Pharmacol; 2021 Aug; 904():174167. PubMed ID: 33974882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
